61
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma

, &
Pages 306-310 | Received 05 Jul 2010, Accepted 19 Sep 2010, Published online: 18 Oct 2010

References

  • Guého E, Smith MT, Hoog GS, . Contributions to a revision of the genus Trichosporon. Antonie van Leeuwenhoek 1992; 61: 289–316.
  • Chagas-Neto T, Chaves G, Colombo A. Update on the genus Trichosporon. Mycopathologia 2008; 166: 121–132.
  • Walsh TJ, Groll A, Hiemenz J, . Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10 (Suppl. 1): 48–66.
  • Rodrigues GDS, de Faria RRU, Guazzelli LS, Oliveira FDM, Severo LC. Nosocomial infection due to Trichosporon asahii: clinical revision of 22 cases. Rev Iberoam Micol 2006; 23: 85–89 [in Spanish].
  • Walsh TJ, Lee JW, Melcher GP, . Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis 1992; 166: 121–133.
  • Krcmery V, Jr. Mateička F, Kunová A, . Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazole. Support Care Cancer 1999; 7: 39–43.
  • Krcmery V, Krupova I, Denning DW. Invasive yeast infections other than Candida spp. in acute leukaemia. J Hosp Infect 1999; 41: 181–194.
  • Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419–4431.
  • Castón-Osorio J, Rivero A, Torre-Cisneros J. Epidemiology of invasive fungal infection. Int J Antimicrob Agents 2008; 32 (Suppl. 2): S103–S109.
  • Girmenia C, Pagano L, Martino B, . Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005; 43: 1818–1828.
  • Fleming RV, Walsh TJ, Anaissie EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am 2002; 16: 915–933, vi–vii.
  • Guého E, Smith MT, Hoog GS. Trichosporon Behrend. Kurtzman CP, Fell JW. The Yeasts, a Taxonomic Study, 4th edn. Amsterdam: Elsevier, 1998: 854–872.
  • Sandhu GS, Kline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections. J Clin Microbiol 1995; 33: 2913–2919.
  • Einsele H, Hebart H, Roller G, . Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997; 35: 1353–1360.
  • Marty FM, Barouch DH, Coakley EP, Baden LR. Disseminated trichosporonosis caused by Trichosporon loubieri. J Clin Microbiol 2003; 41: 5317–5320.
  • Zeng J, de Souza Motta C, Fukushima K, . Identification of Trichosporon spp. strains by sequencing D1/D2 region and sub-typing by sequencing ribosomal intergenic spacer region of ribosomal DNA. J Huazhong Univ Sci Technolog Med Sci 2009; 29: 655–658.
  • Altschul S, Madden T, Schaffer A, . Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 1997; 25: 3389–3402.
  • Padhye AA, Verghese S, Ravichandran P, . Trichosporon loubieri infection in a patient with adult polycystic kidney disease. J Clin Microbiol 2003; 41: 479–482.
  • Walsh TJ, Melcher GP, Lee JW, Pizzo PA. Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol 1993; 5: 79–113.
  • Toriumi Y, Sugita T, Nakajima M, Matsushima T, Shinoda T. Antifungal pharmacodynamic characteristics of amphotericin B against Trichosporon asahii, using time-kill methodology. Microbiol Immunol 2002; 46: 89–93.
  • Espinel-Ingroff A. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 2003; 20: 121–136.
  • Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, . In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother 2002; 46: 1144–1146.
  • Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, . Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 2005; 49: 4026–4034.
  • Walsh TJ, Melcher GP, Rinaldi MG, . Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol 1990; 28: 1616–1622.
  • Wolf DG, Falk R, Hacham M, . Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol 2001; 39: 4420–4425.
  • Anaissie E, Gokaslan A, Hachem R, . Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis 1992; 15: 781–787.
  • Taj-Aldeen SJ, Al-Ansari N, El Shafei S, . Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov. J Clin Microbiol 2009; 47: 1791–1799.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.